Abstract C64: C4BPA identified as a novel biomarker is associated with favorable outcome of patients with pancreatic cancer
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.panca19-c64
Abstract: Introduction: We have previously identified C4b-binding protein α-chain (C4BPA) as a serum biomarker for pancreatic ductal adenocarcinoma (PDAC). Serum C4BPA level was significantly higher, especially in the early stage of PDAC patients, than in healthy… read more here.
Keywords: pancreatic cancer; c4bpa; c4bpa expression; pdac ... See more keywords